Akso Health Group (FRA:8HX)

Akso Health Group Statistics

Total Valuation

FRA:8HX has a market cap or net worth of EUR 702.57 million. The enterprise value is 552.80 million.

Market Cap	702.57M
Enterprise Value	552.80M

Important Dates

The next estimated earnings date is Monday, December 15, 2025.

Earnings Date	Dec 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+504.37%
Shares Change (QoQ)	+44.70%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	551.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	51.39
PB Ratio	3.81
P/TBV Ratio	4.21
P/FCF Ratio	742.52
P/OCF Ratio	645.09
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.43
EV / Sales	43.49
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	584.23

Financial Position

The company has a current ratio of 14.20, with a Debt / Equity ratio of 0.01.

Current Ratio	14.20
Quick Ratio	12.83
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	2.04
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -80.26% and return on invested capital (ROIC) is -1.44%.

Return on Equity (ROE)	-80.26%
Return on Assets (ROA)	-1.37%
Return on Invested Capital (ROIC)	-1.44%
Return on Capital Employed (ROCE)	-1.95%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	27
Asset Turnover	0.08
Inventory Turnover	78.96

Taxes

Income Tax	-28.50M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +63.64% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+63.64%
50-Day Moving Average	1.35
200-Day Moving Average	1.28
Relative Strength Index (RSI)	45.89
Average Volume (20 Days)	1

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.50

Income Statement

In the last 12 months, FRA:8HX had revenue of EUR 13.67 million and -124.88 million in losses. Loss per share was -0.44.

Revenue	13.67M
Gross Profit	-260,468
Operating Income	-3.63M
Pretax Income	-153.83M
Net Income	-124.88M
EBITDA	-1.64M
EBIT	-3.63M
Loss Per Share	-0.44

Balance Sheet

The company has 163.05 million in cash and 1.93 million in debt, giving a net cash position of 161.12 million.

Cash & Cash Equivalents	163.05M
Total Debt	1.93M
Net Cash	161.12M
Net Cash Per Share	n/a
Equity (Book Value)	184.25M
Book Value Per Share	0.33
Working Capital	168.68M

Cash Flow

In the last 12 months, operating cash flow was 1.09 million and capital expenditures -142,906, giving a free cash flow of 946,205.

Operating Cash Flow	1.09M
Capital Expenditures	-142,906
Free Cash Flow	946,205
FCF Per Share	n/a

Margins

Gross Margin	-1.91%
Operating Margin	-26.55%
Pretax Margin	-1,125.14%
Profit Margin	n/a
EBITDA Margin	-12.00%
EBIT Margin	-26.55%
FCF Margin	6.92%

Dividends & Yields

FRA:8HX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-504.37%
Shareholder Yield	-504.37%
Earnings Yield	-17.77%
FCF Yield	0.13%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 24, 2020. It was a reverse split with a ratio of 0.3333333333.

Last Split Date	Aug 24, 2020
Split Type	Reverse
Split Ratio	0.3333333333

Scores

FRA:8HX has an Altman Z-Score of 8.26 and a Piotroski F-Score of 4.

Altman Z-Score	8.26
Piotroski F-Score	4